Characteristics | No. of patients, or range of median |
---|---|
Gender, n (%) (ntotal = 888) |  |
 Male | 557 (62.7) |
 Female | 331 (37.3) |
Age (years) (ntotal = 736) |  |
 Range | 34–91 |
Newly diagnosed or relapsed/refractory, n (%) (ntotal = 997) |  |
 Newly diagnosed | 28 (2.8) |
 Relapsed/refractory | 489 (49.0) |
 Mixed population | 254 (25.5) |
 Not reported | 226 (22.7) |
AL isotype, n (%) (ntotal = 441) |  |
 λ | 387 (87.8) |
 k | 54 (12.2) |
Mayo 2004 Stage, n (%) (ntotal = 303) |  |
 I | 49 (16.2) |
 II | 123 (40.6) |
 III | 50 (16.5) |
 IIIA | 60 (19.8) |
 IIIB | 21 (6.9) |
Mayo 2012 Stage, n (%) (ntotal = 109) |  |
 I | 14 (12.8) |
 II | 36 (33.0) |
 III | 33 (30.3) |
 IV | 26 (23.9) |
Involved organs, n (%) (ntotal = 936) |  |
 Heart | 688 (74.3) |
 Kidney | 560 (60.5) |
 Liver | 76 (8.2) |
 Others* | 34 (3.7) |
eGFR (mL/min/m2) (ntotal = 330) |  |
 Range of median | 34–73 |
dFLC (mg/L) (ntotal = 711) |  |
 Range of median | 34.5–276.9 |